AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA)…Original Article
Pain Therapeutics Announces Feedback from Recent Meeting With FDA on Remoxy
